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Encapsulating bacteria in alginate-based
electrospun nanofibers†
Emily Diep and Jessica D. Schiffman *
Encapsulation technologies are imperative for the safe delivery of live bacteria into the gut where they
regulate bodily functions and human health. In this study, we develop alginate-based nanofibers that
could potentially serve as a biocompatible, edible probiotic delivery system. By systematically exploring
the ratio of three components, the biopolymer alginate (SA), the carrier polymer poly(ethylene oxide)
(PEO), and the FDA approved surfactant polysorbate 80 (PS80), the surface tension and conductivity of
the precursor solutions were optimized to electrospin bead-free fibers with an average diameter of 167 ±
23 nm. Next, the optimized precursor solution (2.8/1.2/3 wt% of SA/PEO/PS80) was loaded with
Escherichia coli (E. coli, 108 CFU mL−1), which served as our model bacterium. We determined that the
bacteria in the precursor solution remained viable after passing through a typical electric field (∼1 kV
cm−1) employed during electrospinning. This is because the microbes are pulled into a sink-like flow,
which encapsulates them into the polymer nanofibers. Upon electrospinning the E. coli-loaded solutions,
beads that were much smaller than the size of an E. coli were initially observed. To compensate for the
addition of bacteria, the SA/PEO/PS80 weight ratio was reoptimized to be 2.5/1.5/3. Smooth fibers with
bulges around the live microbes were formed, as confirmed using fluorescence and scanning electron
microscopy. By dissolving and plating the nanofibers, we found that 2.74 × 105 CFU g−1 of live E. coli cells
were contained within the alginate-based fibers. This work demonstrates the use of electrospinning to
encapsulate live bacteria in alginate-based nanofibers for the potential delivery of probiotics to the gut.
Introduction
Exploration into the gut microbiota has shed light on the
influence that commensal bacteria have on human health and
disease.1 As most of the immune system is found in the gut,1,2
these bacteria help to metabolize nutrients3 and also influence
immune responses.4 Studies have linked the gut microbiota
with ailments including allergies,2 inflammatory bowel
disease,5 multiple sclerosis,6 depression,7 diabetes,8 obesity,9
autism,10 and cancer.3 According to the Food and Agriculture
Organization (FAO) and the World Health Organization
(WHO), probiotic bacteria must be administered to the gut in
high amounts in order to provide therapeutic effects.11–13
The current approach to deliver “probiotics” adopts
pharmaceutical processing and formulations. Probiotic bac-
teria are often freeze-dried, mixed with excipient, and packed
into tablets.14 In terms of processing, freeze drying is a
common method used for the long-term storage of bacteria.
Freezing causes bacteria to enter a hibernation-like state
extending their shelf-life. However, ice formation during freez-
ing can kill bacteria by rupturing their cell membrane. Drying
removes excess water, which causes degradation of the cell and
various molecules within the cell, but it also decreases the like-
lihood of ice formation. To counter these shortcomings,
chemical additives like cryoprotectants are added to the bac-
terial suspension to protect the cells from damage. These addi-
tives include a variety of polymers like lactose,15
fructooligosaccharides,16,17 carboxymethyl high amylose
starch,14 and calcium alginate1,18,19 that effectively encapsulate
the bacteria during the freeze drying process. Additionally,
optimizing the formulation by co-encapsulating probiotics
with prebiotics,17 antacids,20 and fats21 may help bacteria
maintain their viability as they travel through the gastrointesti-
nal tract. Other studies22–24 have shown that the food delivery
matrix of probiotics (e.g. chocolate,25 kimchi,26 yogurt23) affect
their probiotic efficacy in the body.24 The goal of the full for-
mulation is to protect the bacteria against environmental
factors and cell damage during processing and later during
travel through the gastrointestinal tract where the bacteria can
confer beneficial effects.1,14,22
Here, we suggest an alternative approach: to encapsulate
the live microbes into alginate-based nanofiber mats, which
could be ingested. Alginate is a polysaccharide that is compati-
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ble with both the human body and bacterial biofilms making
it an ideal material for the encapsulation of bacteria for deliv-
ery into the gut.27–30 Nanofiber-based technologies are of
growing interest in the drug delivery industry for their high
surface area to volume ratio which allows for controllable
diffusion of active ingredients out of the material.31 During
the electrospinning process, fibers are formed by applying an
electric field onto a polymeric solution to pull the polymers
into solid nanofibers. Fiber formation, diameter, and mor-
phology depend on both solution properties, like concen-
tration, density, conductivity, and surface tension, as well as
experimental parameters, including solution flow rate, tip-to-
collector distance, and applied voltage.32–40 The high surface
area to volume ratios and high porosities of these nanofiber
mats make them suitable for many biomedical applications,
including protective clothing,41 wound dressing,32,42 vascular
grafts,43 and drug delivery.31 Previously, it has been demon-
strated that electrospinning can be used to encapsulate a wide
variety of viable bacteria, including Gram-negative and Gram-
positive cells into dry nanofiber mats.17,39,42,44–47 By adding
glycerol, a cryoprotectant, into the electrospinning precursor
solutions, Escherichia coli (E. coli) and Staphylococcus albus
were encapsulated in polyvinyl alcohol (PVA) fibers with viabil-
ities of 48% and 100% viability, respectively.39 Other bacteria
have also been electrospun into polymers for a range of bio-
medical applications. For example, Staphylococcus epidermidis
has been loaded into carboxymethyl cellulose/polyethylene
oxide (PEO) fibers to treat diabetic foot ulcers,42 and
Lactobacillus acidophilus has been loaded into PVA and polyvi-
nyl pyrrolidone fibers to treat bacterial vaginosis.44 The encap-
sulation and delivery of gut probiotic bacteria from PVA and
PEO fibers has also been demonstrated.17,45,47 However,
research on the encapsulation of microbes into nanofibers fab-
ricated from the generally regarded as safe (GRAS) biopolymer
alginate is scarce; to date the authors are only aware of one
report48 (that was published while we were writing this
manuscript).
Bacteria produce polysaccharides, proteins, and other bio-
polymers which make up their protective biofilm while
encouraging community growth. Polysaccharides, such as algi-
nate, can be used to encapsulate bacteria within a matrix that
mimics their natural environment.27–30 Alginate – linear copo-
lymers of β-(1–4) linked D-mannuronic acid and β-(1–4)-linked
L-guluronic acid units – is well known for its biocompatibility,
sustainability, low cost, and ease of use.29,49 The carboxylic
groups on the alginate chain can be crosslinked with multi-
valent ions, like calcium. Crosslinked alginate materials are
stable in the low pH environment of the stomach, and the
crosslinks are reversed in high pH environments like that of
the intestines. The controllable and reversible nature of these
crosslinks make alginate a promising encapsulation polymer
for the targeted delivery of probiotics to the gut and its
microbiota.22,29,49,50 Alginate hydrogel microbeads have been
previously explored for the encapsulation of drugs,19 pro-
teins,51 and bacteria.20 Unfortunately, the size of these micro-
beads, which range from a few microns to several hundred
microns, limits their use in food-based products as mastica-
tion would immediately break down the beads and release the
encapsulated cargo.51 Electrospinning can be used to form
nanofibers that are much smaller than these microbeads. The
rigid structure of the alginate coupled with its high surface
tension and conductivity in solution has made it a challenge
to electrospin. Some studies have utilized various surfactant
and solvent mixtures to overcome these challenges (e.g., 3.6/
0.4/0.5 wt% SA/PEO/Triton X-100 in water and DMSO,52 2.7/
0.3/0.8 wt% SA/PEO/Triton X-100 in water and ethanol,53 3.2/
0.8/1.5 wt% SA/PEO/Pluronic F127 in water and DMF,54 and
8.0/1.6/2.0 wt% SA/PEO/Pluronic F127 in water).34 While these
published studies have pioneered key parameters for electro-
spinning alginate into nanofibers, none of them have demon-
strated their ability to encapsulate living cells and most fea-
tured cytotoxic solvents.
In this study, we systematically investigated precursor solu-
tions that enabled the electrospinning of smooth alginate-
based nanofibers featuring viable E. coli. Due to its bulky
uronic groups, alginate has a rigid structure that limits chain
entanglements and subsequent electrospinning.34–36 Thus,
previous studies have mixed alginate with “carrier polymers”,
including PEO34–36 and PVA,55,56 so that sufficient chain entan-
glements could be achieved without greatly increasing the vis-
cosity of the precursor solution.34–36 Another precursor addi-
tive, the nonionic surfactant, Triton X-100,34 was previously
reported to enable the formation of bead-free fibers by redu-
cing the surface tension of precursor solution. Here, we
focused on using only GRAS solvents and additives to manu-
facture smooth fibers. PEO was selected as a carrier polymer
because it is biocompatible and can also act as a mucoadhe-
sive for prolonged probiotic presence in the gut.46 We also
investigated the effect of adding polysorbate 80 (PS80), an FDA
approved surfactant, to enable smooth fiber formation during
electrospinning. After optimizing the electrospinning of algi-
nate/PEO/PS80 fibers, we encapsulated bacteria in these algi-
nate-based fibers. We suggest that alginate-based nanofibers
have the potential to protect and deliver a sufficient concen-




All chemicals were used as received without further purifi-
cation. Low viscosity alginic acid sodium salt from brown
algae (SA, ν = 4–12 cP, 1 wt% in H2O at 25 °C), poly(ethylene
oxide) (PEO, Mw = 600 kDa), polysorbate 80 (PS80), tryptone,
sodium chloride (NaCl), yeast extract, agar, potassium chloride
(KCl), sodium phosphate dibasic (Na2HPO4), potassium phos-
phate (KH2PO4), hydrochloric acid (HCl), calcium chloride
(CaCl2), carbenicillin, and propidium iodide (PI) were pur-
chased from Sigma Aldrich (St. Louis, MO). Deionized (DI)
water was obtained from a Barnstead Nanopure Infinity water
purification system (Thermo Fisher Scientific, Waltham, MA).
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E. coli K12 MG1655, engineered with GFP plasmid, was used
throughout our studies as a model microorganism. Overnight
cultures of E. coli were grown in Luria Bertani (LB) broth (10 g
L−1 tryptone, 10 g L−1 NaCl, 5 g L−1 yeast extract in DI water)
with carbenicillin (1 μL mL−1) for 16 h at 37 °C. Cells were har-
vested by centrifugation at 2500g for 5 min at 25 °C (Sorvall™
ST 40R, ThermoFisher Scientific, Waltham, MA). Bacteria
pellets were washed three times with phosphate-buffered
saline (PBS, 8 g L−1 NaCl, 0.2 g L−1 KCl, 1.44 g L−1 Na2HPO4,
0.24 g L−1 KH2PO4 in DI water, adjusted to a pH of 7.4 using
HCl) before being resuspended in sterile DI water.
Electrospinning alginate-based nanofibers loaded with
bacteria
Separate solutions of SA and PEO in sterile DI water were pre-
pared. The two polymeric solutions were mixed with PS80 in
predetermined weight ratios, see the Results and Discussion
section for ratios. SA/PEO/PS80 solutions were mixed for 24 h
at 20 rpm using a Rotator Genie Lab Rotator (Scientific
Industries, Bohemia, NY). To create the bacteria-loaded
electrospinning solutions, a suspension of E. coli was added to
the SA/PEO/PS80 solutions to make a concentration of 108 CFU
mL−1. The solutions were mixed by rotating for at least 1 h at
room temperature (23 °C) before electrospinning.
Electrospinning solutions were loaded into 5 mL Luer-Lock
syringes (Norm-Ject, Tuttlingen, Germany) capped with an
18-gauge hypodermic needle (Exelint, Redondo Beach, CA).
Syringes were secured to a horizontal syringe pump (Cole
Parmer, Vernon Hills, IL) that advanced the solution at a con-
stant volumetric flow rate of 2 mL h−1. The high voltage supply
(Gamma High Voltage Research, Ormond Beach, FL) applied
17.5 kV between the syringe needle and collector plate which
were attached to the supply via alligator clips. The 15 cm × 15 cm
× 0.32 cm copper collector plate covered with aluminum foil was
set at a horizontal separation distance of 17 cm away from the tip
of the needle. Temperature and relative humidity were kept con-
stant at 23 °C and 20–30% using an environmental box.
Characterization of electrospinning solutions
Surface tension measurements were made using a tensiometer
(Optical Contact Angle 20, Dataphysics Inc., GmbH, Germany)
that utilized the drop pendant method. A droplet of solution
was suspended in air from an 18-gauge needle. The needle
gauge was selected because it matches that used for electro-
spinning. The droplet was recorded until reaching equili-
brium; analysis of surface tension was conducted using the
integrated system software (SCA20, Dataphysics Inc., GmbH,
Germany). Conductivity was measured using a conductivity
probe (Tetracon 325, Vernon Hills, IL). Surface tension and
conductivity experiments were conducted in triplicate.
Characterization of alginate-based nanofibers
Visualization of the GFP produced by the encapsulated bac-
teria was captured using a Zeiss Axio Imager A2 M Microscope
(Carl Zeiss Microscopy, White Plains, NY). Micrographs of the
nanofiber mats were taken using scanning electron
microscopy (SEM). Samples were sputter-coated
(Cressington208 Sputter Coater, Watford, UK) with 3 mm of
platinum before imaging using an FEI Magellan 400 XHR-SEM
(ThermoFisher Scientific, Hillsboro, OR). Average nanofiber
diameter distribution was determined by measuring the dia-
meters of 50 random fibers from five micrographs using
ImageJ 1.52a software (National Institutes of Health, Bethesda,
MD).35 Fiber diameter was measured excluding beads or bac-
terial cells. Chemical composition was analyzed using Fourier-
transform infrared spectroscopy (Bruker Alpha, Bruker Optics,
Billerica, MA). Spectra of electrospun fibers were compared to
spectra acquired from dried SA films, dried PEO dry films,
liquid PS80, and dried SA/PEO/PS80 (2.8/1.2/3 wt%) mixture
films.
Bacterial loading in alginate-based solution and nanofibers
The single plate-serial dilution spotting (SP-SDS) drop plate
method51 was used to determine cell viability within the pre-
cursor solutions and fiber mats. To determine bacterial
loading of a solution, solutions were serial diluted. Samples of
20 μL from dilutions were plated on agar plates (10 g L−1 tryp-
tone, 10 g L−1 sodium chloride, 5 g L−1 yeast extract, 15 g L−1
agar, 1 μL mL−1 carbenicillin in DI water).52 Plates were incu-
bated for 16 h at 37 °C. Each bacterium that grew into a dis-
tinct, visible colony was counted as a colony forming unit
(CFU). The quantity of viable bacteria in the electrospun fibers
was determined using a similar method. Instead of a serial
dilution, fiber mats were weighed (Mettler Toldeo XP204,
Columbus, OH) and dissolved in PBS prior to being plated and
counted.
Statistics
Surface tension, conductivity, and bacterial loading are
reported as average values ± standard error, whereas fiber dia-
meter, bead size, and E. coli size were reported as average
values ± standard deviation. A two-sided unpaired Student’s
t-test was used to determine statistical significance reports in
figures, consistent with previous work from our group.57–59
Results and discussion
Effect of surfactant on alginate-based nanofibers
In this study, bead-free alginate-based nanofibers were electro-
spun from a solution of alginate (SA), poly(ethylene oxide)
(PEO), polysorbate 80 (PS80). Each component was optimized
to reduce bead formation along the fiber to create a smooth,
consistent fiber product. Attempts were first made to electro-
spin pure solutions of SA; however, as expected and consistent
with previous works,34,35,60,61 the rigid structure, high surface
tension (47.35 N m−1 for 4 wt% SA), and high conductivity
(8.17 mS cm−1 for 4 wt%) of a pure aqueous SA solution pre-
vented fiber formation (Table 1, Fig. 1). To enable electro-
spinning, 4 wt% of the linear polymer PEO was added to the
Biomaterials Science Paper
































































































4 wt% SA solution in a 3 to 7 ratio to create a 2.8/1.2 wt% SA/
PEO solution. This concentration of SA/PEO was used as a
starting point as it has been electrospun in other studies.34,35
Large beads interconnected by thin fibers or heavily beaded
fibers were produced from this SA/PEO solution (Fig. 2a).
Beading can be caused by factors including low polymer con-
centration,62 slow solution flow rate,63 low applied voltage,64
and low surface tension.34,35,65 In our case, we hypothesized
that the reason for beading was due to high surface tension
which has been shown by other studies to be common for algi-
nate systems.34,35,52,60,61 As the electric field pulls the solution
into a conical jet, surface tension forces attempt to decrease
the surface area per unit of mass turning the jet into spherical
shapes that create the beaded fiber morphology.66
Introducing surfactant into the precursor solution
decreased the surface tension and allowed for the formation of
smooth fibers. We explored the use of a nonionic surfactant,
PS80 because it is an FDA approved surfactant already used in
oral delivery.67 The addition of 0.5 wt% PS80 into the 2.8/
1.2 wt% SA/PEO solution reduced the surface tension by 19%,
to ∼41.93 mN m−1, compared to the surfactant-free solution.
Continuous fibers that were 125 ± 37 nm in diameter were
formed at the smallest incorporation of surfactant (0.5 wt%
PS80), but elongated beads were still present (Fig. 2b).
Increasing the surfactant concentration to 1.0 wt% produced
more spindle-like beads, as well as some smooth fibers
(Fig. 2c). A mixture of beaded and bead-free fibers would alter
the delivery rates of drug loaded fibers.31,68,69 The average dia-
meter was not statistically different compared to the previous
fibers made from 0.5 wt% PS80. As the surface tension
decreased, the fiber diameter (and consequently the fiber
mass) is more consistent along the length of the fiber leading
to smaller, less spherical beads and thicker fiber diameters.66
Smooth fibers with an average fiber diameter of 167 ± 24 nm
were produced by further increasing the surfactant concen-
tration to 3.0 wt% PS80 (Fig. 2d). The presence of surfactant,
in any amount, was able to significantly decrease the surface
tension of the precursor solution compared to the solution
without surfactant. However, a two tailed t-test proved that the
Fig. 1 Conductivity (blue, left axis) and surface tension (pink, right axis)
of polymer solutions. Error bars denote standard error, whereas ** rep-
resents p < 0.1 and *** represents p < 0.01 significance between
samples. Fig. 2 Scanning electron micrographs of fibers electrospun from SA/
PEO (2.8/1.2 wt%) solutions (a) without any surfactant, as well as with (b)
0.5 wt%, (c) 1 wt%, and (d) 3 wt% PS80. Scale bar are 1 µm.
Table 1 Characteristics of precursor solutions and electrospun alginate-based fibers
Precursor solution composition Solution properties Fiber characteristics
Polymer (wt%)
E. coli concentration Conductivitya Surface tensiona Fiber diameterb Bead formation
SA PEO PS80 (CFU mL−1) (mS cm−1) (mN m−1) (nm) (yes/no)
4.0 n/a n/a n/a 8.17 ± 0.21 47.35 ± 2.82 n/a n/a
2.8 1.2 n/a n/a 5.38 ± 0.14 51.70 ± 0.66 n/a Yes
2.8 1.2 0.5 n/a 5.58 ± 0.04 41.92 ± 0.91 125 ± 37 Yes
2.8 1.2 1.0 n/a 5.44 ± 0.05 40.37 ± 0.58 127 ± 38 Yes
2.8 1.2 3.0 n/a 5.04 ± 0.10 39.65 ± 0.63 167 ± 23 No
2.8 1.2 3.0 108 5.28 ± 0.03 41.25 ± 0.24 100 ± 23 Yes
2.8 1.2 5.0 108 5.09 ± 0.05 39.50 ± 0.34 305 ± 110 Yes
2.5 1.5 3.0 108 4.74 ± 0.04 40.43 ± 0.56 273 ± 64 No
a Values are reported as mean ± standard error. b Values are reported as mean ± standard deviation.
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surface tension did not significantly change between the
varying amounts of surfactant, from 0.5–3.0 wt% (Fig. 3).
Similar trends of increasing the surfactant concentration to
reduce beading in SA/PEO electrospun fibers have been
reported in other studies. Saquing et al.35 found that lower
concentrations of Triton X-100 (0.1 wt% and 0.3 wt%) pro-
duced beaded fibers with an 80 to 20 ratio of SA to PEO,
whereas higher concentrations (0.5 wt%, 1 wt%, 1.5 wt%) pro-
duced bead-free fibers. Similar to our study, all these concen-
trations were well above critical micelle concentration (CMC).
At this concentration, surfactant molecules have saturated the
surface of the liquid allowing excess molecules in the bulk
solution to form micelles. Therefore, increasing the surfactant
concentration should not significantly affect surface tension
values after reaching the CMC.70 Yet, changes in morphology
were reported. Notably, different sources of alginate and
varying molecular weights of PEO were used for each of these
studies leading to different weight ratios and concentrations.
It is interesting that various concentrations of surfactant can
be used to form smooth fibers despite the fact that the surface
tension should not change after reaching CMC; this led us to
hypothesize that the surfactant concentration might have a
compounding effect on solution properties, which would
affect fiber formation.
Effect of conductivity on alginate-based nanofibers
We next determined the conductivity of the precursor solu-
tions because sodium alginate dissolved in water has a high
conductivity due to its ionic nature. Notably, high conductivity
can prevent fiber formation by causing strong repulsive forces
between polymer chains that prevent entanglements during
electrospinning.34–36,61,71 One of the reasons that a linear
copolymer, like PEO, is used to electrospin alginate is because
the PEO chains wrap around the rigid alginate chains to inter-
rupt interactions between alginate and sodium ions lowering
the conductivity of the solution.36 We observed this effect, too.
Mixing the SA solution with the PEO solution decreased its
conductivity from 8.17 mS cm−1 (4 wt% SA) to 5.38 mS cm−1
(2.8/1.2 wt% SA/PEO) (Table 1, Fig. 1). Though this change was
statistically significant, bead-free fibers were not formed upon
the addition of PEO into the solution. While the lowest
addition of 0.5 wt% PS80 did not have a statistical effect on
the conductivity of the solution, additional amounts of PS80
significantly decreased the solution conductivity from 5.58 mS
cm−1 (0.5 wt% PS80) to 5.44 mS cm−1 (1.0 wt% PS80) and to
5.04 mS cm−1 (3.0 wt% PS80) (Fig. 3). Increasing the concen-
tration of surfactant above the CMC leads to the formation of
micelles in the bulk solution. These micelles tend to have
lower conductivity than their single-molecule counterparts
thereby decreasing the conductivity of the solution as surfac-
tant concentration increases.72,73
Decreasing conductivity has been previously shown to be
able to supress beading. While electrospinning relies on
charges within the polymer solution to form the Taylor cone, a
highly conductive solution can also be detrimental to the for-
mation of fibers. For example, Zhang et al.63 reported that
when they added protein to their precursor solution, it
increased solution conductivity and was a source of instability
that caused fiber beading. Furthermore, increases in conduc-
tivity decreases the tangential electrostatic force within the
polymer droplet which hinders Taylor cone and subsequent
fiber formation.38,74 In a SA/PEO/Triton X-100 solution,
Saquing et al.35 found that even a low concentration (1 wt%) of
sodium chloride salt which increases solution conductivity
began to decrease fiber formation. A multivalent salt was used
by Fang et al.61 to form calcium alginate fibers. However, their
fibers formed due to the crosslinking of calcium ions with algi-
nate chains, which allowed for entanglement-like interactions
that promoted electrospinning. Conductivities of solutions
used in the aforementioned study remained relatively low due
to the mixed solvent system used (i.e., a combination of DI
water, ethanol, and DMF). Solvents like glycerol60 and DMSO52
also alter interactions between alginate molecules in solution
and aid in fiber formation. In our system, we used an aqueous
solution to ensure that the final product would be safe for con-
sumption as a delivery vehicle for probiotics. In sum, both the
lower surface tension and lower conductivity of the precursor
solution aided in the suppression of the beading in our system
allowing us to form smooth fibers using 2.8/1.2/3 wt% SA/
PEO/PS80 solution (Fig. 2d).
Chemical confirmation of alginate-based nanofibers
In Fig. 4, we confirmed that all components in the precursor
solution were included in the final electrospun nanofiber
product by acquiring Fourier-transform infrared (FTIR) spectra
and comparing them to control spectra of SA, PEO, PS80, and
SA/PEO/PS80. Characteristic peaks of each compound also
appeared in the FTIR spectra of the SA/PEO/PS80 fibers and
control films, thus indicating that all three components were
present. Characteristic peaks in the pure SA spectra included
hydroxyl groups (3500–3000 cm−1 broad peak followed by a
Fig. 3 Conductivity (blue, left axis) and surface tension (pink, right axis)
of 2.8/1.2 wt% SA/PEO solutions with varying concentration of polysor-
bate 80 (PS80). Error bars denote standard error, whereas one asterisk
(*) represents p < 0.5, ** represents p < 0.1, and *** represents p < 0.01
significance between samples.
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sharp peak at 2800 cm−1), asymmetric stretches of carboxylate
anions (1566 cm−1 and 1408 cm−1 peaks), and ester bonds
(1026 cm−1 strong peak).75 Similarly, the PEO spectra exhibited
strong peaks at 2878 cm−1 and 1098 cm−1 indicating terminal
hydrogens and ester groups, respectively. The series of peaks
in the 1460–1180 cm−1 range of the PEO spectra were attribu-
ted to secondary hydrogens along the PEO backbone.76
Different from SA and PEO, the PS80 spectra showed a peak at
1700 cm−1 representing a carbonyl group.77 Indeed, fibers
were comprised of alginate, PEO, and PS80.
Effect of E. coli suspension on fiber morphology
Next, the effect of adding bacteria into the precursor solution
was explored using E. coli K12 MG1655 as a model bacterium.
The previously described optimized 2.8/1.2/3 wt% SA/PEO/
PS80 solution was loaded with 108 CFU mL−1 of E. coli and
electrospun into beaded fibers with an average diameter of 100
± 23 nm (Table 1). The beads present along these bacteria
loaded fibers were 0.81 ± 0.25 μm in length and 0.23 ± 0.04 μm
in width (Fig. 5a). We measured the rod-shaped E. coli cells
using SEM (Fig. S1†), and they were 2.44 ± 0.57 μm in length
by 0.65 ± 0.07 μm in diameter; therefore, we did not suspect
that these beads were bacteria. To be able to differentiate
between these polymer beads and the bacteria, as well as
provide a consistent product, we aimed to once again produce
smooth fibers by adjusting our formulation.
Conductivity and surface tension of bacteria-loaded solu-
tions were determined to explore their role in fiber beading.
These results were compared to the solution properties of the
previously optimized bacteria-free solutions, as shown in
Fig. 6. The change in conductivity due to the addition of bac-
teria in the 2.8/1.2/3 wt% SA/PEO/PS80 solution, though stat-
istically insignificant, was likely due to the negative charge
carried on the surface of the E. coli.78 Škrlec et al.46 saw a
similar increase in conductivity due to the addition of
L. plantarum in their PEO precursor solution and attributed it
to extracellular proteins and ions. Increases in solution con-
ductivity can cause thinner fibers as additional repulsive
charges stretch the electrospinning jet.63 This would explain
the decrease in average fiber diameter due to the addition of
the bacteria. As previously mentioned, increased conductivity
also causes beading along electrospun nanofibers due to
Taylor Cone instability.66 The surface tension of the bacteria-
loaded solution was found to be 41.25 mN m−1. From our pre-
vious studies, high surface tension could also have caused the
beading. Though neither the change in solution conductivity
nor surface tension was statistically significant, we propose
changing these solution properties could compensate for the
addition of E. coli and produce smooth fibers due to previous
indications that these properties influence fiber morphology.
Increasing the PS80 concentration would lower both surface
tension and conductivity as proven by the previous studies. By
Fig. 4 FTIR spectra of SA/PEO/PS80 electrospun nanofibers (black), as
well as control spectra of SA/PEO/PS80 (black), PS80 (pink), PEO (blue),
and SA (green). Dotted lines correspond to characteristic peaks
described in the results that contribute to the SA/PEO/PS80 nanofiber
spectra.
Fig. 5 Scanning electron micrographs of fibers electrospun with 108 CFU mL−1 of E. coli encapsulated in (a) 2.8/1.2/3 wt%, (b) 2.8/1.2/5 wt%, and (c)
2.5/1.5/3 wt% SA/PEO/PS80 precursor solutions. Scale bar are 1 µm.
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increasing the surfactant from 3 to 5 wt% PS80, the 2.8/1.2 wt%
SA/PEO solution with bacteria electrospun into flattened and
webbed structures indicative of wet fibers (Fig. 5b). These fibers
were 305 ± 110 nm in diameter, which was much larger than
any of our previously spun fibers. Surface tension was reduced
to 39.50 mN m−1 compared to the 3 wt% PS80 with bacteria,
which could explain the production of wet fibers. The force of
the electric field that aims to pull entangled polymers out from
the electrospinning droplet to form nanofibers is countered by
the force of surface tension which stabilizes the electrospinning
jet. High surface tension may cause beading, but the low
surface tension cannot hold the jet together.63–65 Therefore,
excess amounts of solution, both polymer and solvent, is
removed from the electrospinning droplet and lands on the col-
lector. In this case, the produced fibers would be larger due to
increased mass flow rate and can be wet due to increased
amounts of solvent being pulled into fibers.64
Alternatively, conductivity and surface tension can be
altered by changing the SA to PEO ratio. PEO chains can inter-
fere with the interaction between sodium ions and alginate
chains which are the major contributors to the conductivity in
this system.34–36,61,71 Therefore, decreasing the concentration
of alginate while increasing the PEO concentration will
decrease the solution conductivity. When the ratio of SA to
PEO was changed from 2.5 to 1.5, the resulting conductivity of
the 2.5/1.5/3 wt% SA/PEO/PS80 solution with 108 CFU mL−1 of
E. coli was 4.74 ± 0.08 mS cm−1, which was significantly lower
than all other bacteria loaded solutions. Consequently, the
surface tension was also altered to a value of 40.43 mN m−1
though this was not significantly different from the 2.8/1.2/
3 wt% SA/PEO/PS80 solution with or without bacteria. We
suspect lower solution conductivity stabilizes the electro-
spinning jet while surface tension allows a moderate amount
of polymer and solvent to be drawn into dry fibers enabling
this solution to produce smooth, bead-free fibers with encap-
sulated E. coli. The optimized fibers containing bacteria were
273.40 ± 62.53 nm in diameter (Fig. 5c).
Viability of bacteria during electrospinning and after
encapsulation in alginate-based fibers
We further analyzed the electrospun fibers with encapsulated
E. coli via fluorescence microscopy and SEM. The GFP which
are produced by metabolically active bacteria can be monitored
using fluorescence microscopy to locate encapsulated bacteria
and confirm their viability. In these micrographs (Fig. 7a, and
S2†), fluorescent bacteria cells appeared to be encapsulated
within the nanofibers. The distinct rod shape of E. coli was
oriented length-wise along the fiber due to a sink-like flow in
the electrospinning jet.39 SEM micrographs were also able to
confirm the encapsulation of bacteria. Bulges appeared along
the length of the fiber which were 2.52 ± 1.14 μm in length
and 0.86 ± 0.05 μm in width (Fig. 7b). These dimensions
closely resemble that of our E. coli (2.44 μm × 0.65 μm),
Fig. S1.†
Previous work on electrospinning live cells (including
mammalian,79,80 yeast,81 and bacterial cells30,39,44–46) have
shown variable results on the viability of encapsulated cells.
Specifically for E. coli strains encapsulated via electrospinning,
viability from 0.1%82 to 48%39,83 has been reported. Severe
declines in viability were attributed dehydration,46,47 cell
rupture,80 and hydrophobicity,45 whereas viability could be
improved with the addition of nutrients, like glycerol39 or pre-
biotics.17 To our knowledge, only one other paper has encapsu-
lated bacteria in alginate-based fibers which was published
while these results were being written. Yilmaz et al.48 pub-
lished a paper on encapsulating Lactobacillus paracasei in elec-
trospun alginate nanofibers. They were able to achieve a bac-
terial loading of 8.57 log (CFU g−1) in their fibers made of 7 to
1 ratio of 20 wt% PVA to 3 wt% SA.
To confirm that we achieved high viability, we determined
how many bacteria were loaded into the precursor solution
versus how many survived encapsulation within the electro-
spun fibers. After conducting our typical mixing protocol, a
sample of the bacteria-loaded precursor solution (2.5/1.5/
3 wt% of SA/PEO/PS80) was serial diluted and plated. The con-
centration of bacteria in solution before electrospinning was
determined to be 4.03 × 109 CFU mL−1 or 9.61 log (CFU mL−1).
Next, we confirmed bacterial viability post exposure to the elec-
Fig. 7 (a) Fluorescent micrograph and (b) scanning electron micro-
graph of GFP producing E. coli in alginate-based fibers. Arrows indicate
the location of E. coli cells. Nanofibers were electrospun from 2.5/1.5/
3 wt% SA/PEO/PS80 solutions with 108 CFU mL−1 of bacteria. Scale bars
are provided.
Fig. 6 Conductivity (blue, left axes) and surface tension (pink, right
axes) of precursors solutions with and without bacteria. Error bars
denote standard error, whereas one asterisk (*) represents p < 0.5.
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tric field.79 During electrospinning, excess precursor solution
falls from the needle tip as the volumetric flow rate exceeds
the rate at which solution is drawn into fibers. These droplets
contain bacteria that have been subjected to the electric field.
In our study, 17.5 kV was applied across a tip-to-collector dis-
tance of 17 cm. After passing through the electric field, 4.94 ×
108 CFU mL−1 or 8.69 log (CFU mL−1) of E. coli cells were
viable, which was statistically equivalent to the concentration
that was loaded in the precursor solution (Fig. 8). Bacteria via-
bility and loading is usually self-defined within an individual
study.17,39,42,44–48 Some studies39,44,48 have reported bacterial
retention as a percentage of the quantity of encapsulated/deli-
vered viable bacteria divided by a measured or theoretical
total. We chose not to report bacterial retention as a percen-
tage because we are comparing bacterial concentrations
between a liquid phase (CFU mL−1 of precursor) and a solid
phase (CFU/gram of nanofiber mat). Notably, this experiment
demonstrates that bacteria remain viable after electrospinning.
Despite the applied voltage,84 the amount of charge that
travels through the bacteria remains low and does not lead to
cell inactivation.64,85 Finally, we determined the number of
viable bacteria encapsulated in our nanofibers by dissolving
and plating the fibers. Bacteria loading in our fibers was deter-
mined to be 2.74 × 105 CFU g−1. Importantly, our system is
made of green chemistries, an FDA approved surfactant, and
aqueous solvent to support biocompatibility with the encapsu-
lated bacteria and potentially to enable delivery to the gut.
The purpose of this paper was to systematically study the
precursor solution properties as they relate to the production
of smooth, alginate-based fibers with bacteria encapsulants;
therefore, techniques used to increase bacterial viability were
beyond the scope of this study. As previously mentioned,
researchers17,39,42,44–47 have also encapsulated high loadings of
bacteria in other polymer nanofibers with the help of co-
encapsulates. While we are encouraged by all of these reports,
more research is needed to understand the correlation
between precursor solution properties, fiber formation, and
the distribution of bacteria in these systems. We suggest that
electrospun fibers that contain a high concentration of algi-
nate hold potential as delivery vehicles to protect and deliver
probiotics to the gut.
Conclusions
This study aimed to encapsulate live bacteria into alginate-
based nanofibers to demonstrate the potential of using these
materials to deliver probiotics to the gut. First, we optimized
the morphology of SA/PEO fibers using the surfactant PS80.
The addition of surfactant decreased both the surface tension
and the conductivity of the precursor solution to form smooth
fibers from a SA/PEO/PS80 (2.8/1.2/3 wt%) solution. Next, a
suspension of E. coli was blended into this polymer solution to
be encapsulated during electrospinning. However, fibers with
a beaded morphology were electrospun from this bacteria-
loaded solution. The polymer concentration was modified to
compensate for the addition of bacteria into the solution, and
smooth fibers were once again produced. The electrospun
solution of 2.5/1.5/3 wt% SA/PEO/PS80 encapsulated 2.74 × 105
CFU g−1 of viable E. coli. These bacteria-loaded and alginate-
based nanofibers could be useful for the delivery of bacteria
into the gut, but more work needs to be conducted to under-
stand the release kinetics. The goal of encapsulating probiotics
is to ensure the delivery of a sufficient concentration of bac-
teria into the gut where they can provide therapeutic effects.
We suggest that by thoroughly understanding how surfactant
and cargo loading impacts precursor solution properties and
subsequently biopolymer fiber formation, that the ease of
encapsulating living active agents into biopolymer fibers can
be facilitated, thus broadening their application space. The
need to deliver living microorganisms using a flexible, porous,
and biocompatible textile will continue to expand in years to
come.
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